A Lifetime of Lung Health: A Global Call to Action on World Lung Day 2026 on September 28, 2026 Posted by
The Hidden Cost of Weight Loss: New Concerns Over Pediatric GLP-1 Use and Nutritional Deficiencies on September 28, 2026 Posted by
A Legacy of Discovery: The Rudensky Symposium and the Future of Immunotherapy on September 28, 2026 Posted by
Decoding the Pit: A Celebrity Pitmaster’s Guide to Navigating the Barbecue Menu on September 28, 2026 Posted by
The Evolution of Spinal Stability: Medtronic’s Infuse™ Bone Graft Receives FDA Approval for TLIF on September 28, 2026 Posted by
The Intersection of GLP-1 Medications and Sleep Apnea: A Comprehensive Guide to Treatment and Coverage on September 28, 2026 Posted by
Advancing the Frontier of Pain Management: Dr. Ball Achieves Medidata Certification on September 28, 2026 Posted by
A Lifetime of Lung Health: A Global Call to Action on World Lung Day 2026 on September 28, 2026 Posted by
The Hidden Cost of Weight Loss: New Concerns Over Pediatric GLP-1 Use and Nutritional Deficiencies on September 28, 2026 Posted by
A Legacy of Discovery: The Rudensky Symposium and the Future of Immunotherapy on September 28, 2026 Posted by
Decoding the Pit: A Celebrity Pitmaster’s Guide to Navigating the Barbecue Menu on September 28, 2026 Posted by
Posted in Digital Health Tools Pharma Pulse: Analyzing the White House Pricing Deals and a Pivot in Huntington’s Research on September 2, 2026
Posted in Medical Innovations Navigating the Regulatory Storm: UniQure’s High-Stakes Path for Huntington’s Gene Therapy on September 2, 2026
Posted in Medical Innovations Roche Abandons Key Huntington’s Disease Pipeline Assets, Dealing a Major Blow to Neurodegenerative Research on July 10, 2026
Posted in Digital Health Tools The Readout LOUD: Breaking Barriers in Huntington’s and Assessing the “MAHA” Mandate on June 19, 2026
Posted in Digital Health Tools A Regulatory Reversal: UniQure’s Path to Approval for Huntington’s Gene Therapy Clears Key Hurdle on June 17, 2026
Posted in Medical Innovations A Regulatory Pivot: UniQure Gains FDA Green Light for Huntington’s Gene Therapy Filing on June 17, 2026
